Janux Therapeutics (JANX) Current Assets (2020 - 2026)
Janux Therapeutics (JANX) posted quarterly Current Assets of $1.0 billion for Q1 2026, down 2.08% year-over-year from $1.0 billion in Q1 2025, and up 2.68% quarter-over-quarter from $975.9 million in Q4 2025.
Janux Therapeutics (JANX) Current Assets (2020 - 2026) Analysis & Trends
Janux Therapeutics (JANX) has reported Current Assets for 7 consecutive years, with $1.0 billion the latest figure, recorded in Q1 2026.
- In Q1 2026, Current Assets fell 2.08% year-over-year to $1.0 billion; the TTM figure through Mar 2026 stood at $1.0 billion (down 2.08% YoY), while the FY2025 annual figure was $975.9 million, down 5.59% from the prior year.
- Current Assets improved to $1.0 billion in Q1 2026 per JANX's latest filing, from $975.9 million in the prior quarter.
- Across five years, Current Assets topped out at $1.0 billion in Q4 2024 and bottomed at $309.3 million in Q2 2023.
- Historically, Current Assets has averaged $632.9 million across 5 years, with a median of $658.7 million in 2024.
- Annual changes were most pronounced in 2023 — Current Assets fell 13.62% — and 2024, when it jumped 195.97%.
- Janux Therapeutics' Current Assets stood at $332.4 million in 2022, then gained by 5.05% to $349.2 million in 2023, then surged by 195.97% to $1.0 billion in 2024, then fell by 5.59% to $975.9 million in 2025, then grew by 2.68% to $1.0 billion in 2026.
- Business Quant data shows JANX's Current Assets at $1.0 billion in Q1 2026, $975.9 million in Q4 2025, and $998.1 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 12.54 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 18.45 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 8.07 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 4.03 Bn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 7.22 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 11.83 Mn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 1.76 Bn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 4.62 Bn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 1.63 Bn |
| 10 | Janux Therapeutics | 984.58 Mn | 984.58 Mn | - | 983.34 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 983.34 Mn |
| Mar 31, 2026 | 1.00 Bn |
| Dec 31, 2025 | 975.89 Mn |
| Sep 30, 2025 | 998.09 Mn |
| Jun 30, 2025 | 1.01 Bn |
| Mar 31, 2025 | 1.02 Bn |
| Dec 31, 2024 | 1.03 Bn |
| Sep 30, 2024 | 666.32 Mn |
| Jun 30, 2024 | 661.94 Mn |
| Mar 31, 2024 | 658.67 Mn |
| Dec 31, 2023 | 349.24 Mn |
| Sep 30, 2023 | 355.20 Mn |
| Jun 30, 2023 | 309.30 Mn |
| Mar 31, 2023 | 321.40 Mn |
| Dec 31, 2022 | 332.44 Mn |
| Sep 30, 2022 | 344.33 Mn |
| Jun 30, 2022 | 358.07 Mn |
| Mar 31, 2022 | 364.65 Mn |
| Dec 31, 2021 | 377.02 Mn |
| Sep 30, 2021 | 389.59 Mn |